Weiguo Hu

Weiguo Hu

Auto-generated profile, based on publicly available information

Weiguo Hu

Shanghai Jiao Tong University School of Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2023 in Journal of Medical Systems
Verified
Journal Article
Closed access
PDF file
XWXinyi Wang
Xinyi Wang
ZGZhenye Gong
Zhenye Gong
GWGuoxin Wang
Guoxin Wang
JJJingdan Jia
Jingdan Jia
YXYing Xu
Ying Xu
XLXiaoyang Li
Xiaoyang Li

16 September 2022 in Science Advances
Verified
Journal Article
Open access
CZChen Zhang
Chen Zhang
HWHan Wang
Han Wang
XYXinhui Yang
Xinhui Yang
ZFZi Fu
Zi Fu
XJXiuru Ji
Xiuru Ji
DNDalong Ni
Dalong Ni
Inflammatory bowel disease (IBD) affects millions of people each year. The overproduction of reactive oxygen species (ROS) plays a critical role in the progress of IBD and will be a potential therapeutic target. Here, we synthesize a kind of oral zero-valent-molybdenum nanodots (ZVMNs) for the treatment of IBD by scavenging ROS. These ultrasmall ZVMNs can successfully pass through the gastric acid and then be absorbed by the intestine. It has been verified that ZVMNs can down-regulate the quantity of ROS and reduce colitis in a mouse IBD model without distinct side effects. In addition, RNA sequencing reveals a further mechanism that the ZVMNs can protect colon tissues from oxidative stress by inhibiting the nuclear factor κB signaling pathway and reducing the production of excessive pro-inflammatory factors. Together, the ZVMNs will offer a promising alternative treatment option for patients suffering from IBD.

8 August 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
CDChenbo Ding
Chenbo Ding
HXHao Xu
Hao Xu
ZYZhibin Yu
Zhibin Yu
MRManolis Roulis
Manolis Roulis
RQRihao Qu
Rihao Qu
HLHua-Bing Li
Hua-Bing Li
γδ T cells are an abundant T cell population at the mucosa and are important in providing immune surveillance as well as maintaining tissue homeostasis. However, despite γδ T cells’ origin in the thymus, detailed mechanisms regulating γδ T cell development remain poorly understood. N 6 -methyladenosine (m 6 A) represents one of the most common posttranscriptional modifications of messenger RNA (mRNA) in mammalian cells, but whether it plays a role in γδ T cell biology is still unclear. Here, we show that depletion of the m 6 A demethylase ALKBH5 in lymphocytes specifically induces an expansion of γδ T cells, which confers enhanced protection against gastrointestinal Salmonella typhimurium infection. Mechanistically, loss of ALKBH5 favors the development of γδ T cell precursors by increasing the abundance of m 6 A RNA modification in thymocytes, which further reduces the expression of several target genes including Notch signaling components Jagged1 and Notch2 . As a result, impairment of Jagged1/Notch2 signaling contributes to enhanced proliferation and differentiation of γδ T cell precursors, leading to an expanded mature γδ T cell repertoire. Taken together, our results indicate a checkpoint role of ALKBH5 and m 6 A modification in the regulation of γδ T cell early development.

4 July 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LSLinhui Shen
Linhui Shen
YZYuan Zong
Yuan Zong
JZJiawen Zhao
Jiawen Zhao
YYYi Yang
Yi Yang
LLLei Li
Lei Li
WHWeiguo Hu
Weiguo Hu
Background: Sarcopenia is a condition characterized by the age-related loss of skeletal muscle mass and function. The pathogenesis of the disease is influenced by chronic low-grade inflammation. However, the specific changes in the immune landscape changes of sarcopenic muscle are not yet fully understood.Methods: To gain insights into the immune cell composition and interactions, we combined single-nucleus RNA sequencing data, bulk RNA sequencing dataset, and comprehensive bioinformatic analyses on the skeletal muscle samples from young, aged, and sarcopenic individuals. Histological staining was then performed on skeletal muscles to validate the distribution of immune cells in clinical samples.Results: We analyzed the transcriptomes of 101,862 single nuclei, revealing a total of 10 major cell types and 6 subclusters of immune cell types within the human skeletal muscle tissues. Notable variations were identified in the immune microenvironment between young and aged skeletal muscle. Among the immune cells from skeletal muscle microenvironment, macrophages constituted the largest fraction. A specific marker gene LYVE1 for skeletal muscle resident macrophages was further identified. Cellular subclasses included four distinct groups of resident macrophages, which play different roles in physiological or non-physiological conditions. Utilizing bulk RNA sequencing data, we observed a significant enrichment of macrophage-rich inflammation in sarcopenia.Conclusions: Our findings demonstrate age-related changes in the composition and cross-talk of immune cells in human skeletal muscle microenvironment, which contribute to chronic inflammation in aged or sarcopenia muscle. Furthermore, macrophages emerge as a potential therapeutic target, thus advancing our understanding of the pathogenesis of sarcopenia.

5 December 2024 in Frontiers in Digital Health
Verified
Journal Article
Open access
PDF file
HJHaijiao Jin
Haijiao Jin
JGJinglu Guo
Jinglu Guo
QLQisheng Lin
Qisheng Lin
SWShaun Wu
Shaun Wu
WHWeiguo Hu
Weiguo Hu
XLXiaoyang Li
Xiaoyang Li
Background: The rapid development of artificial intelligence (AI) has shown great potential in medical document generation. This study aims to evaluate the performance of Claude 3.5-Sonnet, an advanced AI model, in generating discharge summaries for patients with renal insufficiency, compared to human physicians.Methods: A prospective, comparative study was conducted involving 100 patients (50 with acute kidney injury and 50 with chronic kidney disease) from the nephrology department of Ningbo Hangzhou Bay Hospital between January and June 2024. Discharge summaries were independently generated by Claude 3.5-Sonnet and human physicians. The main evaluation indicators included accuracy, generation time, and overall quality.Results: Claude 3.5-Sonnet demonstrated comparable accuracy to human physicians in generating discharge summaries for both AKI (90 vs. 92 points, p > 0.05) and CKD patients (88 vs. 90 points, p > 0.05). The AI model significantly outperformed human physicians in terms of efficiency, requiring only about 30 s to generate a summary compared to over 15 min for physicians (p < 0.001). The overall quality scores showed no significant difference between AI-generated and physician-written summaries for both AKI (26 vs. 27 points, p > 0.05) and CKD patients (25 vs. 26 points, p > 0.05).Conclusion: Claude 3.5-Sonnet demonstrates high efficiency and reliability in generating discharge summaries for patients with renal insufficiency, with accuracy and quality comparable to those of human physicians. These findings suggest that AI has significant potential to improve the efficiency of medical documentation, though further research is needed to optimize its integration into clinical practice and address ethical and privacy concerns.

1 April 2022 in Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
PDF file
JZJing Zhao
Jing Zhao
WHWeiguo Hu
Weiguo Hu
ZZZejia Zhang
Zejia Zhang
ZZZegao Zhou
Zegao Zhou
JDJiayue Duan
Jiayue Duan
CYChangqing Yan
Changqing Yan
Background: Pancreatic cancer seriously threatens human health. Bee venom is a mixture of enzymes, peptides, and amines. Due to its biological activity, bee venom is widely used as an anti-inflammatory agent and pain reliever. However, little is known about the effect of bee venom on pancreatic cancer. Methods: Firstly, the Cell Counting Kit-8 (CCK-8) assay was conducted to analyze the cytotoxicity of bee venom on PANC-1 and AsPC-1 cells. Then, we evaluated the cell cycle and apoptosis by flow cytometry and the terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) assay. In addition, cell migration was analyzed by the cell scratch test and Transwell assay. Western blot was performed to assess the expression of proteins involved in the regulation of cell cycle arrest and apoptosis. Results: Results demonstrated that bee venom significantly suppressed cell proliferation via inducing cell cycle arrest and apoptosis with suppression of cell migration. Bee venom induced S phase arrest and ameliorated the protein expression of cyclins and cyclin-dependent kinases (CDKs). At the same time, bee venom can activate the p53–p21 pathway. Experimental data also showed that bee venom induced cell apoptosis and impeded cell migration. Conclusions: The present study revealed that bee venom could effectively inhibit tumor progression in pancreatic cancer cells, indicating the possibility of bee venom as an anti-tumor drug in pancreatic cancer.